Advised Lundbeck on patent infringement, extension and validity litigation against four generic pharmaceutical companies regarding an anti-depressant sold as Lexapro, in a 14-year dispute in the Patent Office and Federal Court, with success on liability and damages.

The content of this publication is for reference purposes only. It is current at the date of publication. This content does not constitute legal advice and should not be relied upon as such. Legal advice about your specific circumstances should always be obtained before taking any action based on this publication.

Related Capabilities